<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dos Santos IB</submitter><funding>Fundação de Amparo à Pesquisa do Estado de São Paulo</funding><pagination>1427</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6038773</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9</volume><pubmed_abstract>The present study focused on the activity of the palladacycle complex DPPE 1.1 on &lt;i>Leishmania (Leishmania) amazonensis&lt;/i>. Promastigotes of &lt;i>L. (L.) amazonensis&lt;/i> were destroyed &lt;i>in vitro&lt;/i> by nanomolar concentrations of DPPE 1.1, whereas intracellular amastigotes were killed at drug concentrations fivefold less toxic than those harmful to macrophages. &lt;i>L. (L.) amazonensis&lt;/i>-infected BALB/c mice were treated by intralesional injection of DPPE 1.1. Animals treated with 3.5 and 7.0 mg/kg of DPPE 1.1 showed a significant decrease of foot lesion sizes and a parasite load reduction of 93 and 99%, respectively, when compared to untreated controls. Furthermore, DPPE 1.1 was non-toxic to treated animals. The cathepsin B activity of &lt;i>L. (L.) amazonensis&lt;/i> amastigotes was inhibite</pubmed_abstract><journal>Frontiers in microbiology</journal><pubmed_title>Leishmanicidal and Immunomodulatory Activities of the Palladacycle Complex DPPE 1.1, a Potential Candidate for Treatment of Cutaneous Leishmaniasis.</pubmed_title><pmcid>PMC6038773</pmcid><funding_grant_id>(2014/06935-4)</funding_grant_id><funding_grant_id>#2013/02133-8</funding_grant_id><pubmed_authors>Garcia DM</pubmed_authors><pubmed_authors>Teixeira D</pubmed_authors><pubmed_authors>Barbieri CL</pubmed_authors><pubmed_authors>da Silva DAM</pubmed_authors><pubmed_authors>Longo-Maugeri IM</pubmed_authors><pubmed_authors>Katz S</pubmed_authors><pubmed_authors>Dos Santos IB</pubmed_authors><pubmed_authors>Carmona AK</pubmed_authors><pubmed_authors>Paz FACR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Leishmanicidal and Immunomodulatory Activities of the Palladacycle Complex DPPE 1.1, a Potential Candidate for Treatment of Cutaneous Leishmaniasis.</name><description>The present study focused on the activity of the palladacycle complex DPPE 1.1 on &lt;i>Leishmania (Leishmania) amazonensis&lt;/i>. Promastigotes of &lt;i>L. (L.) amazonensis&lt;/i> were destroyed &lt;i>in vitro&lt;/i> by nanomolar concentrations of DPPE 1.1, whereas intracellular amastigotes were killed at drug concentrations fivefold less toxic than those harmful to macrophages. &lt;i>L. (L.) amazonensis&lt;/i>-infected BALB/c mice were treated by intralesional injection of DPPE 1.1. Animals treated with 3.5 and 7.0 mg/kg of DPPE 1.1 showed a significant decrease of foot lesion sizes and a parasite load reduction of 93 and 99%, respectively, when compared to untreated controls. Furthermore, DPPE 1.1 was non-toxic to treated animals. The cathepsin B activity of &lt;i>L. (L.) amazonensis&lt;/i> amastigotes was inhibite</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018</publication><modification>2025-04-26T08:19:46.125Z</modification><creation>2019-03-26T23:46:55Z</creation></dates><accession>S-EPMC6038773</accession><cross_references><pubmed>30018604</pubmed><doi>10.3389/fmicb.2018.01427</doi></cross_references></HashMap>